Literature DB >> 34283880

Improved glycaemia during the Covid-19 pandemic lockdown is sustained post-lockdown and during the "Eat Out to Help Out" Government Scheme, in adults with Type 1 diabetes in the United Kingdom.

Parizad Avari1, Rebecca Unsworth1, Siân Rilstone1, Chukwuma Uduku1, Karen M Logan2, Neil E Hill1, Ian F Godsland1, Monika Reddy1, Nick Oliver1.   

Abstract

AIMS: The majority of studies report that the Covid-19 pandemic lockdown did not have a detrimental effect on glycaemia. We sought to explore the impact of lockdown on glycaemia and whether this is sustained following easing of restrictions.
METHODS: Retrospective, observational analysis in adults and children with type 1 diabetes attending a UK specialist centre, using real-time or intermittently scanned continuous glucose monitoring. Data from the following 28-day time periods were collected: (i) pre-lockdown; (ii) during lockdown; (iii) immediately after lockdown; and (iv) a month following relaxation of restrictions (coinciding with Government-subsidised restaurant food). Data were analysed for times in glycaemic ranges and are expressed as median (IQR).
RESULTS: 145 adults aged 35.5 (25.8-51.3) years with diabetes duration of 19.0 (7.0-29.0) years on multiple daily injections of insulin (60%) and continuous insulin infusion (40%) were included. In adults, % time in range (70-180mg/dL) increased during lockdown (60.2 (45.2-69.3)%) compared to pre-lockdown (56.7 (43.5-65.3)%; p<0.001). This was maintained in the post-lockdown time periods. Similarly, % time above range (>180mg/dL) reduced in lockdown compared to pre-lockdown (p = 0.01), which was sustained thereafter. In children, no significant changes to glycaemia were observed during lockdown. In multivariable analysis, a greater increase in %TIR 3.9-10mmol/L (70-180mg/dL) during lockdown was associated with higher levels of deprivation (coefficient: 4.208, 95% CI 0.588 to 7.828; p = 0.02).
CONCLUSIONS: Glycaemia in adults improved during lockdown, with people from more deprived areas most likely to benefit. This effect was sustained after easing of restrictions, with government-subsidised restaurant eating having no adverse impact on glycaemia.

Entities:  

Year:  2021        PMID: 34283880     DOI: 10.1371/journal.pone.0254951

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  33 in total

Review 1.  Type 1 diabetes in adults: supporting self management.

Authors:  Monika Reddy; Sian Rilstone; Philippa Cooper; Nick S Oliver
Journal:  BMJ       Date:  2016-03-10

2.  Glycemic Control in Type 1 Diabetes Mellitus During COVID-19 Quarantine and the Role of In-Home Physical Activity.

Authors:  Gianluca Tornese; Viola Ceconi; Lorenzo Monasta; Claudia Carletti; Elena Faleschini; Egidio Barbi
Journal:  Diabetes Technol Ther       Date:  2020-05-21       Impact factor: 6.118

3.  Glycemic control in type 1 diabetes mellitus and COVID-19 lockdown: What comes after a "quarantine"?

Authors:  Viola Ceconi; Egidio Barbi; Gianluca Tornese
Journal:  J Diabetes       Date:  2020-10-02       Impact factor: 4.006

4.  Updated Software for Automated Assessment of Glucose Variability and Quality of Glycemic Control in Diabetes.

Authors:  Vanessa Moscardó; Marga Giménez; Nick Oliver; Nathan R Hill
Journal:  Diabetes Technol Ther       Date:  2020-04-22       Impact factor: 6.118

5.  Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic.

Authors:  Barbara Predieri; Francesco Leo; Francesco Candia; Laura Lucaccioni; Simona F Madeo; Marisa Pugliese; Valentina Vivaccia; Patrizia Bruzzi; Lorenzo Iughetti
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-07       Impact factor: 5.555

6.  Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics.

Authors:  Ernesto Maddaloni; Raffaella Buzzetti
Journal:  Diabetes Metab Res Rev       Date:  2020-03-31       Impact factor: 4.876

7.  Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study.

Authors:  Emma Barron; Chirag Bakhai; Partha Kar; Andy Weaver; Dominique Bradley; Hassan Ismail; Peter Knighton; Naomi Holman; Kamlesh Khunti; Naveed Sattar; Nicholas J Wareham; Bob Young; Jonathan Valabhji
Journal:  Lancet Diabetes Endocrinol       Date:  2020-08-13       Impact factor: 32.069

8.  The challenge of diabetes home control in COVID-19 times: Proof is in the pudding.

Authors:  Laura Cotovad-Bellas; Cristina Tejera-Pérez; Alma Prieto-Tenreiro; Ana Sánchez-Bao; Diego Bellido-Guerrero
Journal:  Diabetes Res Clin Pract       Date:  2020-08-25       Impact factor: 5.602

9.  The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring.

Authors:  Alex Mesa; Clara Viñals; Irene Pueyo; Daria Roca; Mercè Vidal; Marga Giménez; Ignacio Conget
Journal:  Diabetes Res Clin Pract       Date:  2020-07-30       Impact factor: 5.602

10.  Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown.

Authors:  Avivit Brener; Kineret Mazor-Aronovitch; Marianna Rachmiel; Noa Levek; Galia Barash; Orit Pinhas-Hamiel; Yael Lebenthal; Zohar Landau
Journal:  Acta Diabetol       Date:  2020-10-07       Impact factor: 4.280

View more
  1 in total

1.  Impact of COVID-19 lockdown on diabetes management and follow-up in a broad population in Spain.

Authors:  Ana Palanca; Carmen Quinones-Torrelo; Juan Girbés; José T Real; F Javier Ampudia-Blasco
Journal:  Eur J Clin Invest       Date:  2022-03-27       Impact factor: 5.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.